HRGN OTC
Harvard Apparatus Regenerative Technology Inc.
1W: +11.2%
1M: -4.8%
3M: +108.6%
YTD: +19.0%
$2.19
-0.01 (-0.45%)
Weekly Expected Move ±17.6%
$1
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$646K
-139.3% ▼
Operating Income
-$8M
+6.6% ▲
Net Income
-$7M
+11.2% ▲
EPS (Diluted)
$-0.42
+19.2% ▲
EBITDA
-$8M
+6.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $0 |
| YoY Growth | +0.0% |
| Cost of Revenue | $646K |
| Gross Profit | -$646K |
| Gross Margin | — |
| R&D Expenses | $3M |
| SG&A Expenses | $4M |
| Operating Expenses | $7M |
| Operating Income | -$8M |
| Operating Margin | — |
| Interest Expense | -$8K |
| Income Before Tax | -$7M |
| Tax Expense | $0 |
| Net Income | -$7M |
| Net Margin | — |
| EPS (Diluted) | $-0.42 |
| EBITDA | -$8M |
| Shares Outstanding | 17M |